Immunohistochemistry AMACR Test: Advanced Prostate Cancer Detection
Understanding the Immunohistochemistry AMACR Test
The Immunohistochemistry AMACR Test represents a breakthrough in prostate cancer diagnostics, utilizing cutting-edge molecular techniques to detect Alpha-Methylacyl-CoA Racemase (AMACR), a specific biomarker highly expressed in prostate cancer cells. This sophisticated diagnostic tool has revolutionized how pathologists identify and characterize prostate malignancies, providing unprecedented accuracy in distinguishing between benign conditions and cancerous growths.
Immunohistochemistry (IHC) involves applying specific antibodies that bind to AMACR proteins in tissue samples, creating visible staining patterns that pathologists can analyze under a microscope. The presence of AMACR, also known as P504S, serves as a reliable indicator of prostate cancer, making this test an essential component of modern cancer diagnostics and personalized treatment planning.
What the AMACR Test Measures and Detects
The Immunohistochemistry AMACR Test specifically measures the expression levels of Alpha-Methylacyl-CoA Racemase protein in prostate tissue samples. This enzyme plays a crucial role in fatty acid metabolism and becomes significantly overexpressed in prostate cancer cells compared to normal prostate tissue.
Key Detection Capabilities:
- Identifies AMACR protein overexpression in prostate tissue
- Distinguishes between benign prostate hyperplasia and malignant cancer
- Detects high-grade prostatic intraepithelial neoplasia (HGPIN)
- Helps identify small foci of cancer in challenging biopsy samples
- Provides complementary information alongside traditional histopathology
Who Should Consider the AMACR Test
This advanced diagnostic test is recommended for individuals presenting with specific clinical indications that warrant detailed prostate cancer evaluation.
Primary Candidates Include:
- Patients with persistently elevated PSA levels despite negative initial biopsies
- Individuals with abnormal digital rectal examination findings
- Those with atypical small acinar proliferation (ASAP) in previous biopsies
- Patients with high-grade prostatic intraepithelial neoplasia (HGPIN)
- Individuals requiring clarification of ambiguous prostate biopsy results
- Patients being monitored for cancer recurrence after treatment
Significant Benefits of AMACR Testing
The Immunohistochemistry AMACR Test offers numerous advantages for both patients and healthcare providers, enhancing diagnostic accuracy and treatment outcomes.
Key Benefits:
- Enhanced Diagnostic Accuracy: Reduces false-negative results by identifying cancer cells that might be missed by conventional methods
- Early Cancer Detection: Enables identification of prostate cancer at earlier, more treatable stages
- Personalized Treatment Planning: Provides critical information for developing targeted treatment strategies
- Reduced Unnecessary Procedures: Helps avoid repeat biopsies when initial results are ambiguous
- Improved Prognostic Assessment: Offers insights into cancer aggressiveness and potential progression
- Cost-Effective Diagnosis: At only $76 USD, provides high-value diagnostic information
Understanding Your AMACR Test Results
Interpreting AMACR test results requires professional medical expertise, but understanding the basic principles can help patients engage more effectively in their healthcare journey.
Result Interpretation Guidelines:
- Positive AMACR Staining: Indicates the presence of AMACR protein, strongly suggesting prostate cancer. The intensity and pattern of staining provide additional information about cancer characteristics.
- Negative AMACR Staining: Suggests the absence of significant AMACR expression, typically indicating benign tissue. However, some rare prostate cancers may not express AMACR.
- Focal Positive Staining: Limited areas of AMACR expression may indicate early or small cancer foci requiring careful evaluation.
- Combined Analysis: Results are always interpreted in conjunction with traditional histopathology and other clinical findings for comprehensive assessment.
Your healthcare provider will discuss your specific results in detail, explaining what they mean for your individual situation and next steps in your care plan.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry AMACR Test | $76 USD | $126 USD |
Nationwide Accessibility
GGC DNA maintains comprehensive testing facilities across the United States, ensuring convenient access to the Immunohistochemistry AMACR Test in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified laboratories guarantees consistent, high-quality results regardless of your location.
Sample Requirements and Processing
For accurate AMACR testing, proper sample collection and handling are essential. We accept:
- Tumor tissue preserved in 10% formal-saline solution
- Formalin-fixed paraffin-embedded tissue blocks
- Shipment at room temperature with appropriate packaging
Required Documentation:
- Complete histopathology report
- Detailed site of biopsy information
- Comprehensive clinical history
Turnaround Time
- Standard Tissue Biopsy: 5 days
- Large Complex Tissue Samples: 7 days
- Daily Sample Acceptance: Until 6:00 PM
Take Control of Your Prostate Health Today
Don’t leave your prostate health to chance. The Immunohistochemistry AMACR Test provides the clarity and confidence you need for informed healthcare decisions. With our special discounted price of only $76 USD, advanced prostate cancer detection has never been more accessible.
Ready to schedule your test? Contact our dedicated healthcare team today:
Call or WhatsApp: +1(267) 388-9828
Our experienced medical professionals are available to answer your questions, discuss your concerns, and help you schedule your AMACR test at your convenience. Early detection saves lives – take the first step toward prostate health assurance today.
